Lower peak bone mass and osteopenia at puberty have been reported in 27%–38% of AIS patients, suggesting that AIS may be correlated with hormonal disturbances involving estrogen, melatonin and leptin (Ishida et al., 2015). This evidence concerns the gene LEP and androgen insensitivity syndrome.